Is It Time to Bring Your TMF In-House?

As a sponsor, bringing your eTMF in-house and having your CROs work directly in your eTMF can provide long-term benefits, including more control over your data, better oversight, and continual digital inspection readiness in line with the latest EMA expectations.

Hear GW Pharmaceuticals’ experiences on the below topics:

• The value of an in-house eTMF for better access, real-time control, and inspection readiness
• How to avoid costly and high-risk end-of-study migrations and ensure compliance with GCP guidelines for digital inspections
• CRO training and user access management
• Rapid, cost-effective deployment options